• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - CORK EMBOZENE¿ MICROSPHERES; AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - CORK EMBOZENE¿ MICROSPHERES; AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS Back to Search Results
Model Number 01-0301-04002-07
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Headache (1880); Pain (1994)
Event Date 04/01/2018
Event Type  Injury  
Manufacturer Narrative
Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.(b)(4).
 
Event Description
It was reported that the patient experienced headaches and claudication.The patient underwent an embolization of the right and left internal maxillary arteries using 400um embozene¿ microspheres in (b)(6) 2018.In (b)(6) 2018, the patient developed headaches on bilateral hemicrania predominantly on the left side, claudication of the jaw, and induration of the temporal right artery with hyperesthesia of bilateral scalp.The physician prescribed corticotherapy of 0.7mg / kg for one month allowing a regression of all symptoms.Ten days after discontinuation of corticosteroids the headaches reappeared.
 
Manufacturer Narrative
Describe event or problem, name prefix, last name, occupation: updated.(b)(4).
 
Event Description
It was further reported that the patient's headaches were caused by giant cell arteritis and possibly related to the embozene spheres.The headaches began a few days post embolization procedure.The patient did not have a prior history of headaches.The patient is in good condition under corticotherapy.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMBOZENE¿ MICROSPHERES
Type of Device
AGENTS,EMBOLIC,FOR TREATMENT OF UTERINE FIBROIDS
Manufacturer (Section D)
BOSTON SCIENTIFIC - CORK
business and technology park
model farm road
cork
EI 
MDR Report Key7655912
MDR Text Key112995776
Report Number2134265-2018-05873
Device Sequence Number1
Product Code NAJ
Combination Product (y/n)N
PMA/PMN Number
K141209
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 06/07/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/02/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/11/2020
Device Model Number01-0301-04002-07
Device Catalogue Number14020-S1
Device Lot Number21148118
Was Device Available for Evaluation? No
Date Manufacturer Received07/20/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-